This indicator measures early HIV diagnosis in infants.
- High coverage of early virological testing of infants helps initiate ART early in children with confirmed HIV infection and supports counselling on efforts to prevent seroconversion of those with a negative early test result.
- Current PMTCT guidelines recommend virological testing for HIV-exposed infants within 2 months of birth.
Number of HIV-exposed infants born during the reporting period who received a virological HIV test within 2 months (and 12 months) of birth
Estimated number of HIV-positive women who delivered during the reporting period
For the numerator. Programme records (for example, PMTCT registers, laboratory records)
For the denominator. Modelling-based estimates (for example, Spectrum AIM)
Note: The denominator is a proxy measure for the number of infants born to HIV-infected women.
The recommended reporting period is 12 months.
Disaggregation of the numerator
- Test result (HIV-positive, HIV-negative, indeterminate, other) to enable calculation of the percentage positive and the percentage with an indeterminate result among HIV-exposed infants receiving a virological test
- Age of infant (<2 months, 2-12 months) to allow the separate calculation of the proportion of exposed infants receiving virological testing within 2 months of birth and within 12 months of birth.
WHO Strategic Information Guidelines, 2020 (https://indicatorregistry.unaids.org/sites/default/files/9789240000735-eng.pdf)
2.1 Early infant diagnosis, Global AIDS Monitoring 2020: Indicators for monitoring the 2016 Political Declaration on Ending AIDS (https://www.unaids.org/sites/default/files/media_asset/global-aids-monitoring_en.pdf).
PMTCT_EID, PEPFAR, MER 2.0 (Version 2.4), September 2019, Monitoring, Evaluation, and Reporting (https://www.state.gov/wp-content/uploads/2019/10/PEPFAR-MER-Indicator-Reference-Guide-Version-2.4-FY20.pdf).